BIKTARVY® (bictegravir 50/emtricitabine 200mg/tenofovir alafenamide 25mg) tablets HCP

Biktarvy® (bictegravir 50/emtricitabine 200mg/tenofovir alafenamide 25mg) tablets hcp email format

Verified email-pattern data for Biktarvy® (Bictegravir 50/emtricitabine 200mg/tenofovir Alafenamide 25mg) Tablets Hcp is currently limited. You can still use the company insights and contact sections below.
Please see full Prescribing Information, including BOXED WARNING, available at BiktarvyPI.com, in the pinned post, and at BiktarvyHCP.com. Please see Indication and Important Safety Information below in the pinned post and at https://www.biktarvyhcp.com/important-safety-information. This product information is intended for US Healthcare Professionals only. To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc., at 1-800-445-3235 (option #3) or the FDA at 1-800-FDA-1088 or fda.gov/medwatch. BIKTARVY, the BIKTARVY Logo, FOR TODAY, TOMORROW, AND THE DAYS TO COME, GILEAD, the GILEAD Logo, and GSI are trademarks of Gilead Sciences, Inc., or its related companies. © 2024 Gilead Sciences, Inc. All rights reserved. US-BVYP-0985 08/24
Looking for a particular BIKTARVY® (bictegravir 50/emtricitabine 200mg/tenofovir alafenamide 25mg) tablets HCP employee's phone or email?

Biktarvy® (Bictegravir 50/emtricitabine 200mg/tenofovir Alafenamide 25mg) Tablets Hcp Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant